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ABSTRACT
High Mobility Group A (HMGA) is a family of
architectural nuclear factors which play an
important role in neoplastic transformation.
HMGA proteins are multifunctional factors that
associate both with DNA and nuclear proteins that
have been involved in several nuclear processes
including transcription. HMGA localization is
exclusively nuclear but, to date, the mechanism
of nuclear import for these proteins remains
unknown. Here, we report the identification and
characterization of a nuclear localization signal
(NLS) for HMGA2, a member of the HMGA family.
The NLS overlaps with the second of the three
AT-hooks, the DNA-binding domains characteristic
for this group of proteins. The functionality of
this NLS was demonstrated by its ability to target
a heterologous b-galactosidase/green fluorescent
protein fusion protein to the nucleus. Mutations
to alanine of basic residues within the second
AT-hook resulted in inhibition of HMGA2 nuclear
localization and impairment of its function in
activating the cyclin A promoter. In addition,
HMGA2 was shown to directly interact with the
nuclear import receptor importin-a2 via the second
AT-hook. HMGA proteins are overexpressed and
rearranged in a variety of tumors; our findings can
thus help elucidating their role in neoplastic
transformation.
INTRODUCTION
The High Mobility Group A (HMGA1a, HMGA1b
and HMGA2) are non-histone chromatin proteins
which participate in a variety of cellular processes,
including gene transcription, integration of retroviruses
into chromatin, induction of neoplastic transformation
and promotion of metastatic progression (1).
HMGA1a and HMGA1b, together referred to as
HMGA1, result from alternative splicing of the same
gene and diﬀer for an internal region of 11 amino acids
(2), while the highly homologous HMGA2 derives from
a diﬀerent but related gene (3).
The expression level of HMGA is maximal during
embryonic development but is low in fully diﬀerentiated
cells (1). Consistent with a role in proliferation and
diﬀerentiation, homozygous mutations in the Hmga2
gene result in the pygmy or ‘mini-mouse’ phenotype (4),
while haploinsuﬃciency of the Hmga1 gene causes cardiac
hypertrophy and myelo-lymphoproliferative disorders
in mice (5). In addition, lack of HMGA1 causes insulin
resistance and diabetes in humans and mice (6).
In several human tumor cells, the HMGA1 protein
level is high and correlates with the increasing degree
of malignancy or metastatic potential, suggesting its
use as a molecular marker for malignancy (1). HMGA2
expression is more restricted and was reported to
localize to the invasive front of carcinomas, where
cells exhibit epithelial–mesenchymal transition (7).
Indeed, it has been recently reported that transforming
growth factor-b employs HMGA2 to elicit epithelial–
mesenchymal transition (8). Of additional interest,
rearrangements of the HMGA2 gene resulting in loss
of the acidic C-terminal tail, have been frequently
detected in benign human tumors, mostly of
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played by HMGA proteins in neoplastic transformation
is given by overexpression of HMGA proteins, which
was shown to promote a transformed phenotype in
diﬀerent cell lines, and by transgenic mice overexpres-
sing HMGA which develop tumors (1,10,11). Recently,
a novel role for HMGA in cellular senescence has been
reported, adding more complexity to the functions
played by this group of proteins (12).
HMGA proteins consist of about 100 amino acid
residues and are characterized by the presence of
three DNA-binding domains called ‘AT-hooks’, which
preferentially bind to the narrow minor groove of AT-rich
DNA sequences. Because of their intrinsic ﬂexibility,
HMGA proteins participate in speciﬁc protein–DNA and
protein–protein interactions inducing both structural
changes in chromatin and formation of stereospeciﬁc
high-order complexes called ‘enhanceosomes’ on the
promoter/enhancer DNA sequences, regulating expression
of a large number of mammalian genes (1,13). One of the
best-studied mechanisms of gene regulation in
which HMGA1 has been involved in is that of the
interferon-b gene (IFN-b) (14). HMGA2 instead
has been reported to associate with the transcriptional
repressor p120
E4F and to activate the cyclin A gene
(15) and more recently to interact with pRB inducing
E2F1 activity playing a crucial role in pituitary
tumorigenesis (16).
Even though HMGA are considered important nodes in
the chromatin protein network, the precise mechanisms of
nuclear import for these proteins remain unknown.
To determine the mechanism of nuclear import for
HMGA proteins, we used a deletion mutagenesis
approach on HMGA2 and identiﬁed a NLS corres-
ponding to the second AT-hook of the protein.
Expression of this sequence in fusion with a heterologous
b-galactosidase (b-gal) and green ﬂuorescent protein
(GFP) eﬃciently directs nuclear targeting, thereby demon-
strating functionality of this NLS. Point mutations of the
basic residues within the NLS, in the context of full length
protein, strongly inhibit HMGA2 nuclear localization and
the ability to activate the cyclin A, a known HMGA2
target gene (15). Moreover, since the region identiﬁed is
identical in all HMGA proteins, these results can be
expected to be extended to the entire HMGA family. Our
data provide the ﬁrst reported mechanism of nuclear
import for a HMGA protein and might help in ﬁnding
strategies able to interfere with the nuclear localization
and function of these proteins.
MATERIALS AND METHODS
Cells,tissue culture anddrug treatments
NIH-3T3 (Mouse ﬁbroblast), CHO (Chinese hamster
ovary), HeLa (human cervical carcinoma) and 293
(human embryonic kidney) cell lines were grown in
Dulbecco’s modiﬁed Eagle’s medium supplemented with
fetal calf serum (10%), L-glutammine (4mM), penicillin
(100units/ml) and streptomycin (100mg/ml) at 378Ci n5 %
CO2 atmosphere. Ratjadone C (Alexis Corporation,
Lausen, Switzerland) treatment was performed for 6h
at a ﬁnal concentration of 5ng/ml. Ratjadone C is an
analogue of the nuclear export inhibitor leptomycin B.
Plasmid constructs
Plasmids expressing the wild-type and C-terminal deletion
mutants of the human HMGA2 protein in fusion with
b-gal and GFP, were generated via PCR using pcDNA3
HMGA2 (15) as template and the primers (carrying
the restriction site, underlined, indicated in brackets)
summarized in Table 1. Plasmids pHM829 HMGA2,
pHM829 HMGA2 1-83, pHM829 HMGA2 1-73 and
pHM829 HMGA2 1-54 were created using as upstream
primer the A2_109up oligonucleotide and, as downstream,
the primers A2_109dw, A2_83dw, A2_73dw and A2_54dw
respectively. Plasmid pHM829 HMGA2 1-43 was
obtained with A2_43up and A2_43dw primers. PCR
products were digested with the appropriate restriction
enzymes and ligated into the pHM829 plasmid (17), a kind
gift of Dr. T. Stamminger.
Plasmid pEGFP HMGA2 was generated by PCR with
pcDNA3 HMGA2 as a template, and the primers
A2EGFP_up and A2EGFP_dw (see Table 1). Primers
were designed to incorporate a 50 Hind III site and a
30 Bam HI site (underlined) into the PCR product, for
subsequent restriction and ligation into the pEGFP-N1
plasmid (Clontech Laboratories, Palo Alto, CA).
Plasmid pcDNA3HA TrxA2-45/53 was created by
cloning into the Rsr II site of pcDNA3HATrx plasmid
(15), carrying the E. coli thioredoxin ORF, the A2_45/53s
and A2_45/53as oligonucleotides (see Table 1), which were
phosphorylated and annealed; plasmid pcDNA3HA
TrxA2-45/63 was created in the same way using the
A2_45/63s and A2_45/63as oligonucleotides. Plasmids
pHM829 TRX, pHM829 TRXA2-45/63 and pHM829
TRXA2-45/53 were created via PCR using as template
the pcDNA3HATrx, pcDNA3HATrxA2-45/63 and
pcDNA3HATrxA2-45/53 plasmids respectively, and
the TRXup and TRXdw primers summarized in
Table 1. Plasmid pGFP-HDAC4 was a kind gift from
Dr. C. Brancolini, plasmid pGEX3X-Pendulin (importin-
a2) was supplied by Dr B. Birshtein, plasmid pGEX4T1
importin-b was supplied by Dr I. Mattaj. Plasmid
pGL2CycAwt was previously described (15).
Site-directed mutagenesis
Plasmids pEGFP-HMGA2mS2 (K46A/R47A),
pEGFP-HMGA2mS3 (K46A/R47A/R49A), pEGFP-
HMGA2mS4 (K46A/R47A/R49A/R51A), pEGFP-
HMGA2mS5 (K46A/R47A/R49A/R51A/K53A) and
pEGFP-HMGA2mT6 (K74A/R75A/R77A/R79A/R81A/
K82A) were obtained using the QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA). The mutagen-
esis reaction was performed following the manufacturer’s
protocol using as template the pEGFP HMGA2 plasmid
for pEGFP-HMGA2mS2, the pEGFP-HMGA2mS2
for pEGFP-HMGA2mS3, the pEGFP-HMGA2mS3 for
pEGFP-HMGA2mS4, the pEGFP-HMGA2mS4 for
pEGFP-HMGA2mS5.
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site-directed mutagenesis steps of lysine and arginine
residues to alanine: pEGFP-HMGA2mT2 (K74A/R75A),
pEGFP-HMGA2mT3 (K74A/R75A/R77A) and
pEGFP-HMGA2mT5 (K74A/R75A/R77A/R81A/
K82A). Mutagenesis products were obtained as follows:
HMGA2 mS2 using primer A2_mS2up and primer
A2_mS2dw; HMGA2 mS3 using A2_mS3up and
A2_mS3dw; HMGA2 mS4 using A2_mS4up and
A2_mS4dw; HMGA2 mS5 using A2_mS5up and
A2_mS5dw; HMGA2 mT2 using A2_mT2up and
A2_mT2dw; HMGA2 mT3 using A2_mT3up and
A2_mT3dw; HMGA2 mT5 using A2_mT5up and
A2_mT5dw; HMGA2 mT6 using A2_mT6up and
A2_mT6dw, respectively (see Table 1). Nucleotide
sequence of each construct was veriﬁed by automated
sequencing.
Transfections and luciferase assays
Transfections by the standard calcium phosphate
precipitation method and reporter gene assays were
performed essentially as previously described (15). Cells
were plated at a density of 0.5 10
6 cells per 60-mm
diameter culture dish and processed 24h after removal
of the precipitates. For luciferase assay, cells were
transfected with 1mg of the CycA reporter construct
(pGL2CycAwt) and 3mg of the pEGFP HMGA2wt,
pEGFP-HMGA2mS5 and pEGFP-HMGA2mT6 vectors
respectively. 0.1mg of pRL-CMV Renilla luciferase
expression vector (Promega Corporation, Madison, WI)
was included to normalize for transfection eﬃciencies. The
assay was performed using the dual-luciferase reporter
assay system (Promega) according to manufacturer’s
instructions. Luciferase activity was assayed on a Lumat
LB 9501 Luminometer (Berthold, Bad Wildbad,
Germany). For cell imaging, cells were transfected with
4mg of the indicated plasmid.
Confocal microscopyand imaging
For cell imaging, cells grown onto coverslips were washed
twice in PBS, ﬁxed in ice cold 3% paraformaldehyde
in PBS at room temperature for 20min, treated with
100mM glycine in PBS for 5min at room temperature,
permeabilized with 0.5% Triton X-100 in PBS for 5min
at room temperature, then washed twice in PBS. Nuclei
were stained with propidium iodide at a ﬁnal concentra-
tion of 5mg/ml in PBS containing 400mg/ml RNAse A
(Sigma-Aldrich, St. Louis, MO), for 20min at 378C.
Coverslips were ﬁnally washed extensively with PBS and
mounted onto glass slides with Mowiol (pH¼8.5)
solution. Cells were imaged with a Leica TCS SP micro-
scope with a 488–543nm Argon laser. Fluorescence
relative intensity was quantitated by analyzing acquired
TIFF-format images with the ImageJ software (version
1.36); at least one hundred cells from each diﬀerent
experiment were subjected to quantitation analysis.
Westernblot analysis
Sixteen hours after removal of the precipitates, transfected
cells were washed twice with ice cold PBS, harvested
from the plates and transferred to Eppendorf tubes,
then lysed in 62mM Tris (pH¼6.8), 2% SDS,
5% beta-mercaptoethanol, 10% glycerol, 1mM phenyl-
methylsulfonyl ﬂuoride, and protease inhibitors (Sigma)
Table 1. Name and sequence of oligonucleotides used in this work
Oligo name Oligo sequence
A2EGFPup 50-GAT TAC GCT AAG CTT ATG AGC
GCA-30(Hind III)
A2EGFPdw 50-GAC CGG TGG GGA TCC GTC CTC TTC
G-30 (Bam HI)
A2_109up 50-GAT TAC GCT GCT AGC ATG AGC GCA-30 (Nhe I)
A2_109dw 50-GAC CGG TGG TCT AGA GTC CTC TTC G-30
(Xba I)
A2_83dw 50-AAC AAC TTG TCT AGA CCA TTT CCT AG-30
(Xba I)
A2_73dw 50-GCC TCT TGG TCT AGA TTC TCC AGT GG-30
(Xba I)
A2_54dw 50-GGA CTC TTG TTT CTA GAG CCT TTG GGT
C-30 (Xba I)
A2_43up 50CTC GAG CTC CCG CGG ATG AGC GCA-30 (Sac II)
A2_43dw 50-GAC CGG TGG TCT AGA GGG CTC ACC-30
(Xba I)
A2_45/53s 50-GTC CGC CTA AGA GAC CCA GGG GAA GAC
CCA AAG CCG-30
A2_45/53as 50-GAC CGG CTT TGG GTC TTC CCC TGG GTC
TCT TAG GCG-30
A2_45/63s 50-GTC CGC CTA AGA GAC CCA GGG GAA GAC
CCA AAG GCA GCA AAA ACA AGA GTC CCT
CTA AAG CAG CCG-30
A2_45/63as 50-GAC CGG CTG CTT TAG AGG GAC TCT TGT
TTT TGC TGC CTT TGG GTC TTC CCC TGG GTC
TCT TAG GCG -30
TRXup 50-TCA ATG CTA GCG CCA CCA TGG GCG ATA-
30 (Nhe I)
TRXdw 50-TGA TTC CGC GGC TTT CCA AGT CGG TTC
AT-30 (Sac II)
A2_mS2up 50-GGT GAG CCC TCT CCT GCC GCA CCC AGG
GGA AGA CCC-30
A2_mS2dw 50GGG TCT TCC CCT GGG TGC GGC AGG AGA
GGG CTC ACC-30
A2_mS3up 50-CCT GCC GCA CCC GCG GGA AGA CCC AAA
GG-30
A2_mS3dw 50-CCT TTG GGT CTT CCC GCG GGT GCG GCA
GG-30
A2_mS4up 50-CGC ACC CGC GGG AGC ACC CAA AGG CAG
C-30
A2_mS4dw 50-GCT GCC TTT GGG TGC TCC CGC GGG TGC
G-30
A2_mS5up 50-CGC GGG AGC ACC CGC AGG CAG CAA AAA
CAA-30
A2_mS5dw 50-TTG TTT TTG CTG CCT GCG GGT GCT CCC
GCG-30
A2_mT2up 50-GCA GAA GCC ACT GGA GAA GCC GCG CCA
AGA GCC AGA CCT AGG-30
A2_mT2dw 50-CCT AGG TCT GCC TCT TGG CGC GGC TTC
TCC AGT GGC TTC TGC-30
A2_mT3up 50-AGA AGC CGC GCC AGC AGG CAG ACC TAG
GA-30
A2_mT3dw 50-TCC TAG GTC TGC CTG CTG GCG CGG CTT
CT-30
A2_mT5up 50-CGC CAG CAG GCA GAC CTG CCG CAT GGC
CAC AAC AAG TTG TTC AG-30
A2_mT5dw 50-CTG AAC AAC TTG TTG TGG CCA TGC GGC
AGG TCT GCC TGC TGG CG-30
A2_mT6up 50-CGC CAG CAG GCG CAC CTG CCG CAT GG-30
A2_mT6dw 50-CCA TGC GGC AGG TGC GCC TGC TGG CG-30
Primers used in this work, as indicated in material and methods.
The underlined sequences indicate the restriction site of the enzyme
reported in brackets.
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tion and resolved by sodium dodecyl sulfate polyacryla-
mide-gel electrophoresis (SDS-PAGE). Proteins were
transferred from the gel to a nitrocellulose membrane
using the Multiphor II semi-dry transfer apparatus
(Amersham Biosciences, Uppsala, Sweden). Membranes
were blocked at room temperature with 5% non-fat milk
powder in PBS (pH¼7.4) and 0.1% Tween-20 before
incubating overnight at 48C with polyclonal rabbit anti-
GFP primary antibody (a kind gift from Dr. C.
Brancolini) or polyclonal rabbit anti HMGA2 primary
antibody (15). Membranes were then washed extensively
with PBS and 0.1% Tween-20, and incubated for 2h
at room temperature with horseradish peroxidase-
conjugated goat anti-rabbit secondary antibody (Sigma).
Finally, membranes were washed extensively as
described above, and processed using the SuperSignal
West Femto chemiluminescence substrate (Pierce
Biotechnology, Rockford, IL) following the manufac-
turer’s protocol.
Invitro translation (IVT) and GST pull-down assay
IVT of wild-type and deletion mutants of the human
HMGA2 protein were performed using the TnT-coupled
Transcription and Translation kit (Promega) with
[
35S]methionine (NEN Life Science, Boston, MA), accord-
ing to manufacturer’s instructions.
Expression and puriﬁcation of recombinant GST fusion
proteins were carried out with standard protocols.
GST-pull-down assays were performed, essentially as
previously described (15), by incubating 5mg of recombi-
nant GST importin-a2, GST importin-b and GST proteins
bound to beads with 10ml of the in vitro translated
proteins in 200ml of binding buﬀer (25mM HEPES pH
7.9, 50mM NaCl, 1mM DTT, 0.01% NP-40). After 2h of
incubation at room temperature, the protein-bound beads
were washed twice in complete binding buﬀer (binding
buﬀer plus 0.25% BSA) and twice in binding buﬀer
without BSA. The bound proteins were then eluted and
analyzed by SDS-PAGE (T¼8%) and autoradiography.
RESULTS AND DISCUSSION
Basic residues within the second AT-hook arenecessary
fornuclear localization
To identify regions of HMGA2 that could serve as
a nuclear localization signal (NLS), we performed deletion
mutagenesis analysis using a previously described in vivo
assay designed speciﬁcally for the identiﬁcation of
NLSs (17). We generated four deletion mutants of the
human HMGA2 removing progressively sequences from
the C-terminal tail. These HMGA2 fragments result
simultaneously fused at the N-terminal to b-galactosidase
(b-gal) and at the C-terminal to green ﬂuorescent
protein (GFP) (Figure 1A). This system is particularly
advantageous since it adds bulk (b-gal contributes with
86kDa) preventing passive diﬀusion through the nuclear
pore, since small GFP fusion proteins could be subjected
to passive diﬀusion through nuclear pores and to
proteolytic degradation. The diﬀerent constructs were
transiently transfected in NIH-3T3 cells and subcellular
localization was monitored by laser confocal microscopy.
As depicted in Figure 1B, full-length HMGA2 fusion
protein (HMGA2 1-109) accumulates exclusively into
the nucleus and is mostly localized into the large
heterochromatinic regions which can be positively stained
with 40-6-Diamidino-2-phenylindole (DAPI) (data not
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Figure 1. Identiﬁcation of HMGA2 nuclear localization signal by
deletion mutagenesis. (A) Schematic representation of HMGA2 deletion
mutants; each deletion mutant is fused to b-gal at the N-terminus, and
to GFP at the C-terminus. Summary of intracellular localization is
indicated at the right. (B) NIH-3T3 cells were transfected with HMGA2
deletion mutants constructs, and fusion proteins were visualized by
confocal laser microscopy. Propidium iodide (PI) staining of the same
nuclei is shown. At least one hundred cells per transfection were
analyzed in three diﬀerent experiments. Bars, 10mm. (C) Western blot
analysis performed with an anti-GFP antibody.
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similar to that described for HMGA proteins and to
that obtained by staining the endogenous HMGA2
protein with anti-HMGA2 speciﬁc antibodies (18,19 and
data not shown).
Deletion of regions from the C-terminus tail that retain
the second AT-hook (HMGA2 1-83, HMGA2 1-73,
HMGA2 1-54) show an exclusive nuclear localization,
as the full-length HMGA2 1-109 does, while the removal
of the second AT-hook (HMGA2 1-43) results in
a cytoplasmic localization of the fusion protein, as for
the empty b-gal/GFP vector (Figure 1B). As shown in
Figure 1C, all the fusion proteins show the expected
molecular weight. Experiments were performed with NIH-
3T3 cells but similar results were obtained with HeLa and
293 cells (data not shown).
With the deletion mutagenesis analysis, we restricted the
NLS to an 11 amino acid region corresponding to the
second AT-hook. HMGA2 has three AT-hooks which are
highly conserved among HMGA proteins and which allow
them to interact with the minor groove of AT-rich DNA
sequences. Interestingly, even though their sequence is
very similar, the ﬁrst and the third AT-hook do not seem
to be involved in nuclear localization since the removal of
the third (construct HMGA2 1-73) does not prevent
nuclear localization while the presence of the ﬁrst
(construct HMGA2 1-43) is not suﬃcient (Figure 1B).
NLSs are often characterized by clusters of basic amino
acid residues, in particular the classical monopartite NLS
is composed of a single cluster of basic residues (20).
Within the second AT-hook there are ﬁve basic residues
that could potentially serve as a monopartite NLS. To
better deﬁne the NLS, we generated EGFP fusion
constructs (HMGA2 mS2-EGFP, HMGA2 mS3-EGFP,
HMGA2 mS4-EGFP and HMGA2 mS5-EGFP) in which
we progressively mutated these basic residues to alanine
and tested them for cellular localization (Figure 2).
A construct with all the six basic residues of the third
AT-hook converted to alanine (HMGA2 mT6-EGFP) was
also included as control. As shown in Figure 2B, the
mutation of the ﬁrst two basic residues (K46, R47)
to alanines (HMGA2 mS2-EGFP) disrupts normal sub-
cellular localization, since a cytoplasmic ﬂuorescence can
be detected. To better quantify the inﬂuence of the
mutated residues in nuclear localization, the ratio between
nuclear and cytoplasmatic ﬂuorescence was quantiﬁed
with a digital software analysis system. Figure 2B and C
show that progressive mutation of basic residues within
the second AT-hook leads to an increase in cytoplasmatic
ﬂuorescence which is, with HMGA2 mS5-EGFP, compar-
able to that of the empty vector. Diﬀerently, the construct
with all six basic residues of the third AT-hook mutated
to alanines (HMGA2 mT6-EGFP) displays the same
nuclear localization of wild type HMGA2. As shown in
Figure 2D, mutations within the basic residues do not
aﬀect the integrity of the fusion proteins. To further
conﬁrm these results, the HMGA2 sequences of
HMGA2 mS5 and HMGA2 mT6 were cloned in fusion
with b-gal and GFP, as described above. Results did
conﬁrm complete nuclear localization for HMGA2
mT6 and cytoplasmatic localization for HMGA2 mS5
(data not shown).
ThesecondAT-hook(aminoacidresidues45–53)isnecessary
andsufficient fornuclear localization
To directly test the second AT-hook for NLS function-
ality, we generated expression constructs (TrxA2 45-63
and TrxA2 45-53) in which the regions from amino acid 45
to 63 and 45 to 53 were inserted within the active site of
the E. coli thioredoxin (Trx), ﬂanked at the N-terminus
with b-gal and at the C-terminus with GFP (Figure 3A).
Trx is largely used as scaﬀold since it provides conforma-
tional constraint and stability to short peptide sequences
(15). These constructs were transiently transfected in NIH-
3T3 cells and both showed an exclusive nuclear localiza-
tion in contrast with the empty vector containing Trx
which localized into the cytoplasm (Figure 3B).
The integrity of the expressed proteins was controlled
by Western blot, as shown in Figure 3C.
These experiments do demonstrate that the second
AT-hook, in particular the region from amino acid 45 to
53, is necessary and suﬃcient to drive nuclear localization.
This region is highly conserved in HMGA2 proteins
of diﬀerent species and it is also conserved in the other
HMGA proteins – HMGA1a and HMGA1b – of diﬀerent
species (Figure 3D). Interestingly, our ﬁndings imply also
a nuclear localization for HMGA1c, a less abundant
and poorly characterized splice variant of HMGA1
whose sequence retains the ﬁrst two AT-hooks and
whose C-terminus diﬀers completely from the other
two isoforms HMGA1a and HMGA1b (21). We therefore
believe that our results can be applied to the entire
HMGA family and to diﬀerent species of vertebrates.
In addition, despite the presence of several other basic
residues within the HMGA2 sequence, our data indicate
a basic monopartite NLS type for HMGA proteins.
We next tested whether cytoplasmic accumulation
of HMGA2 mutants was due to removal of a NLS and
was not due to decryption of a nuclear export signal
(NES) which could be exposed as a consequence
of the mutations. Cells transfected with constructs
HMGA2 1-43 and HMGA2 mS5-EGFP were treated
with the nuclear export pathway inhibitor ratjadone C.
This compound, an analogue of leptomycin B, binds and
inhibits the function of Crm1 protein, a critical mediator
of nuclear export pathways (22). Results indicate that
ratjadone C treatment had no eﬀect on the cytoplasmic
accumulation of both mutants (Figure 4). This result
suggests that cytoplasmic accumulation of the mutant
proteins results from NLS disruption and not from
exposure of a cryptic NES. As a positive control for
ratjadone C activity, we used a GFP-HDAC4 construct,
which has been shown to contain an active NES (23).
As expected, GFP-HDAC4 cytoplasmic localization is
inhibited following drug treatment, resulting in nuclear
accumulation (Figure 4).
Importin-amediates HMGA2 nuclear transport
The ﬁnding of a basic monopartite NLS suggested that
HMGA2 might bind the conventional nuclear import
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nuclear translocation. This pathway initiates with the
binding of importin-a to the NLS of a substrate protein.
Importin-a then binds importin-b to the NLS and this
heterotrimeric complex enters the nuclear pore complex
and translocates into the nucleus. There are, however,
many exceptions to this kind of import, derived from the
presence of diﬀerent kinds of cytoplasm receptors that can
recognize the NLS, or from the ability of the NLS to bind
directly to importin-b, independently upon importin-a,
or from the presence of proteins that can translocate
through the nuclear pore complex in the absence of any
soluble factors (20). To investigate whether HMGA2
directly interacts with importin-a, we performed GST
pull-down experiments. Figure 5A shows that in vitro
translated HA-tagged HMGA2 eﬃciently binds GST
importin-a2 but not GST importin-b or GST alone.
BSAP/Pax-5 transcription factor was used as a positive
control since it was previously reported to bind
importin-a2 (24). To map the region in HMGA2 which
is recognized by importin-a2, in vitro translated HMGA2
deletion constructs (HMGA2 1-83, HMGA2 1-73,
HMGA2 1-54 and HMGA2 1-43) produced in fusion
with b-gal and GFP were employed. As it can be seen
in Figure 5B, deletions from the C terminal of HMGA2
did not aﬀect binding to importin-a2 as long as the second
AT-hook is maintained (HMGA2 1-83, HMGA2 1-73,
HMGA2 1-54). A further deletion removing the second
AT-hook (HMGA2 1-43) abolishes almost completely
importin-a2 binding. To demonstrate that the region
comprising the second AT-hook is necessary and suﬃcient
for importin-a2 binding, a GST pull-down experiment was
performed using constructs TrxA2 45-63 and TrxA2
45-53. Results indicated that even the shortest construct
consisting of nine residues of the second AT-hook is
able to bind eﬃciently importin-a2 (Figure 5C).
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Figure 2. Basic residues of the second AT-hook of HMGA2 are responsible for nuclear localization of fusion proteins. (A) Partial sequences of point-
mutated constructs of HMGA2. Basic residues were replaced with alanine residues as indicated. Each point-mutant is fused C-terminally with EGFP
(not drawn); numbers identify positions of residues on HMGA2 protein sequence. Summary of intracellular localization is indicated at right. (B)
NIH-3T3 cells were transfected with HMGA2 point-mutant constructs, and fusion proteins were visualized by confocal laser microscopy. Propidium
iodide (PI) staining of the same nuclei is shown. At least one hundred cells per transfection were analyzed in three diﬀerent experiments, and at least
one hundred cells per transfection were subjected to ﬂuorescence quantiﬁcation. Bars, 10mm. (C) For each point-mutant construct, nuclear and
cytoplasmic ﬂuorescence were quantiﬁed, and percentage of nuclear localization was calculated. Bars indicate percentage standard
deviation. (D) The expression and integrity of the fusion proteins were analyzed by Western blot using anti-GFP antibody.
1756 Nucleic Acids Research, 2007, Vol. 35, No. 6Taken together, therefore, these results demonstrate
that sequence from aa 45 to 53 is necessary and suﬃcient
to drive nuclear localization of HMGA2 and for binding
to importin-a2.
The second AT-hook iscritical forHMGA2 function
To demonstrate that the basic residues within the second
AT-hook are not only the critical determinants for
HMGA2 nuclear localization but also are responsible
for HMGA2 function, we tested HMGA2 mS5-EGFP
in transient transfection experiments, and HMGA2
mT6-EGFP as a control, along with a cyclin A reporter
for luciferase induction (Figure 6A). We have in fact
previously demonstrated that HMGA2 is able to induce
the cyclin A gene through the cyclic AMP-responsive
element (CRE). This eﬀect is mediated by HMGA2
association with transcription factors binding to
CRE and, since the region involved included the
second AT-hook, possibly also by HMGA2-DNA
interaction (15).
Consistent with our previous report, wild type HMGA2
in fusion with EGFP is able to eﬃciently induce the
reporter gene (Figure 6B). Mutations within the second
AT-hook (construct HMGA2 mS5) completely abolish
HMGA2-mediated induction, while mutations within
the third AT-hook (construct HMGA2 mT6) do not
alter the activity of HMGA2 on the reporter gene.
Nuclear localization signals of many transcription
factors are localized onto DNA binding domains and
electrostatic interactions between positively charged basic
residues and the negatively charged phosphate DNA
backbone are the predominant mediators of nucleic acid
binding (25). Indeed NMR studies have demonstrated
the relevant function played by basic residues within
the second AT-hook of HMGA1 in establishing contacts
with DNA bases (26). Therefore our work demonstrates
that basic residues within the second AT-hook are critical
determinants for HMGA2 nuclear localization and for
HMGA2 function. Moreover, since the second AT-hook
of HMGA proteins is the main region involved in protein–
protein interactions with most of HMGA partners
(16,27,28), our ﬁndings further stress the relevance of
this domain in HMGA family.
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Figure 3. The second AT-hook of HMGA2 constitutes a nuclear
localization signal. (A) Schematic representation of fusion proteins
which include second AT-hook; each fusion protein is formed by the
b-gal at the N-terminus, thioredoxin in which peptides coding for
the second AT-hook (aminoacids 45–63 or 45–53) are expressed within
the catalytic domain, and GFP at the C-terminus. Summary of
intracellular localization is indicated on the right. (B) NIH-3T3 cells
were transfected with HMGA2 peptide containing constructs, and
fusion proteins were visualized by confocal laser microscopy. Fusion
protein including the peptide sequence PKRPRGRPK (amminoacids
from 45 to 53 of HMGA2) localizes into the nucleus (more than 95%
of transfected cells). At least one hundred cells per transfection
were analyzed in three diﬀerent experiments. Bars, 10mm. (C) The
expression and integrity of the fusion proteins were conﬁrmed by
Western blot using anti-GFP antibody. (D) Alignment of amminoacid
sequences of the second AT-hook of HMGA2 and HMGA1 proteins,
and ﬂanking residues. Sequences show very high conservation, and
residues of the second AT-hook are identical (bolded and dot boxed) in
all of the HMGA2 proteins from H. sapiens to D. rerio, as well as
in the HMGA1 proteins from H. sapiens to G. gallus (while D. rerio
sequence has one diﬀerence in a basic residue [R4K]). Sequences were
obtained from public databases (HMGA2: H. sapiens NP_003474;
C. hircus BAB64336; G. gallus NP_990332; M. musculus NP_835158;
R. norvegicus NP_114459; X. tropicalis AL955898; X. laevis
AAH82363; D. rerio NP_997845; HMGA1: H. sapiens NP_665911;
C. familiaris NP_001003387; B. Taurus XP_888488; C. griseus
AAF06666; M. musculus NP_057869; P. troglodytes XP_530918;
R. norvegicus NP_647543; G. gallus AAQ63840; D. rerio AAH44554).
Nucleic Acids Research, 2007, Vol. 35, No. 6 1757HMGA proteins are known to be subjected to extensive
post-translational modiﬁcations which aﬀect their
function (1). The second AT-hook of HMGA2 is ﬂanked
by two residues, S44 and S55, which can be phosphory-
lated. The ﬁrst one was shown to be phosphorylated
in vitro by p34/cdc2 while the second bears a consensus for
PKC. Both consensus are conserved in HMGA1 and the
residues were reported to be phosphorylated in vitro and
in vivo (1). Phosphorylation within – or adjacent to – a
classic NLS sequence can negatively modulate nuclear
localization interfering with binding of cargo proteins
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GFP-HDAC4
HMGA2 mS5-EGFP
C
−+
6h Ratjadone C
C
C= N
C
N
C= N
Figure 4. Cytoplasmic localization of b-gal/GFP HMGA2 1-43 and
HMGA2 point-mutant mS5-EGFP does not result from exposure of a
cryptic nuclear export signal. NIH-3T3 cells were transfected with
either HMGA2 1-43, HMGA2 mS5-EGFP and GFP-HDAC4
constructs, and fusion proteins were visualized by confocal laser
microscopy. Cells were either untreated ( ) or treated (þ) with 5ng/ml
ratjadone C for 6h. On the contrary of GFP-HDAC4, localization
of b-gal/GFP HMGA2 1-43 and HMGA2 mS5-EGFP does not
change following treatment with the nuclear export inhibitor. At least
one hundred cells per transfection were analyzed in three diﬀerent
experiments, and more than 95% of transfected cells showed the
representative staining. Bars, 10mm.
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Figure 5. The second AT-hook of HMGA2 interacts directly with
importin-a2. (A)
35S-radiolabeled in vitro translated HA-tagged
HMGA2 was incubated with equivalent amounts of GST, GST
importin-a2 and GST importin-b immobilized on Sepharose beads.
20% of the in vitro translated reactions used in the pull-down
experiments was included as input. As a control, the same experiment
was performed with HA-tagged BSAP. (B) To determine the HMGA2
domain involved in importin-a2 interaction,
35S-radiolabeled in vitro
translated HMGA2, together with the indicated C-terminal deletion
mutants cloned in fusion with b-gal and GFP, were incubated with
Sepharose immobilized GST importin-a2 or GST in GST pull-down
assays as described in A. Only the deletion mutant HMGA2 1-43 that
lacks the second AT-hook has lost the ability of binding importin-a2.
(C)
35S-radiolabeled in vitro translated peptides corresponding to the
second AT-hook within the thioredoxin scaﬀold and in fusion with
b-gal and GFP were incubated with GST-importin-a2 or GST
immobilized on Sepharose beads in GST pull-down assays as described
in A. The size of all the IVT products are in agreement with the
expected molecular weights.
1758 Nucleic Acids Research, 2007, Vol. 35, No. 6to importin (29). We therefore tested this possibility by
producing a double mutant (S44E, S55E) where serine
residues were replaced by glutamic acid that should
mimick a constitutive phosphorylation. However,
repeated experiments in NIH-3T3 cells always showed
an exclusive nuclear localization of this double mutant,
even when ﬂuorescence was monitored at early stages after
transfection, suggesting therefore a strict nuclear localiza-
tion for HMGA2 protein which is independent of
phosphorylation (data not shown).
Although some works reported also a cytoplasmic
localization for HMGA proteins (30–32), HMGA locali-
zation seems to be strictly nuclear, as this family of
proteins performs several functions at nuclear level, the
most relevant being the involvement in transcription
regulation. The HMGA2 gene has been described as the
most frequent target of cytogenetic rearrangements
in human neoplasms. In fact both HMGA genes,
in particular HMGA2, are mutated in several tumors
of mesenchymal origin such as lipomas, leiomyomas
and hamartomas and have been implicated in the
pathogenesis of these tumors (1,9). HMGA alterations
result in production of deleted or chimeric proteins that
have lost, in the vast majority of the cases, the C-terminal
domain but retain the three AT-hooks, while only in some
cases also the third AT-hook is lost. An important
consequence of our study is therefore that all these deleted
or chimeric proteins retain their NLS and are therefore
nuclear although the function of the protein could be
altered due to ectopic or deleted sequences.
The function of many key proteins involved in cell
growth, such as p53 and NF-B, can be regulated by their
cellular localization and nuclear transport has been
suggested as a potential target for alteration of cell
growth (33). HMGA proteins are both overexpressed and
rearranged in several tumors; therefore, molecular strate-
gies able to interfere with their nuclear localization could
be important tools to interfere with their transforming
activity. The deﬁnition of the NLS, reported in this work,
could lay the bases for further studies towards this aim.
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